Worker’s Comp Paying for Medical Marijuana? – Court Rules Insurers Can Reimburse Injured Workers for Weed Costs

March 23, 2023 · Cannabis.net

The Pennsylvania Appellate Court made a groundbreaking ruling, allowing workers’ compensation laws to cover medical cannabis expenses. Paul Sheetz, the deceased plaintiff, treated his chronic pain with medical cannabis after a work injury in 1977. He also used cannabis to wean off prescribed opioids. The defendant, Firestone, argued that reimbursing medical cannabis costs would violate federal law, but the court disagreed. The court ruled that insurers are not recommending cannabis, so it is not a federal crime.

This decision benefits those who rely on medical cannabis for work-related injury treatment. Medical cannabis expenses were previously not covered by workers’ compensation laws, which left many injured workers to cover the high costs of this alternative treatment. But the court’s recent ruling acknowledges the value of this treatment method and provides financial assistance to those who depend on it.

Court Ruling

The justices were divided on a case regarding medical marijuana use for work-related injuries. The Workers’ Compensation Appeal Board rejected the plaintiff’s request to reimburse medical marijuana costs. However, the justices ruled that this decision was wrong and overturned it.

Judge Anne Covey stressed that the employer’s failure to pay for the plaintiff’s medical marijuana violated the Workers’ Compensation Act. This verdict establishes the employer’s obligation to cover all essential medical treatments, such as medical marijuana. The court’s decision favoring the plaintiff over the Workers’ Compensation Appeal Board sets a precedent for similar cases involving medical marijuana and workers’ compensation. This ruling is a crucial step toward equitable treatment of all injured workers.

The Pennsylvania Medical Marijuana Act (MMA) stipulates that lawful medication use cannot impede the rights of medical marijuana patients. Similarly, the Workers’ Compensation (WC) Act obligates employers to cover necessary medical expenses for work-related injuries. If the court sided with the employer’s argument against covering medical marijuana expenses under the WC Act, it would violate both the MMA and the WC Act’s explicit patient protections. This could set a dangerous precedent for medical marijuana patients’ rights statewide.

The presiding judge clarified that the General Assembly intended to protect medical marijuana patients’ rights when they enacted the MMA. The statute’s unambiguous language guarantees that patients, including those with Workers’ Compensation claims, can access the latest medical treatments for their well-being. The General Assembly’s commitment to protecting medical marijuana patients’ rights is evident in the MMA’s explicit declaration and intention. This includes ensuring patients have access to the latest medical treatments, which can be life-changing for those with work-related injuries.

Public Opinion About the Ruling

The court’s decision to allow medical marijuana reimbursement under workers’ compensation is a positive step for patients seeking alternative pain relief. However, some have reservations about potential abuse and insurance coverage mandates.

NORML’s Deputy Director, Paul Armentano, sees the court’s decision as progress towards recognizing medical cannabis as a valid treatment option. As more people discover its potential benefits, policymakers and courts will have no choice but to adapt their views and policies.

For many people, medical cannabis is a safe and effective alternative for many patients with chronic pain and debilitating conditions. It offers an alternative to traditional pharmaceutical treatments, often with risks of adverse side effects or addiction. With the increased acceptance of medical cannabis, its role in managing medical conditions becomes clearer.

The use of medical cannabis in the workplace remains a highly debated topic in the United States. While some states explicitly allow employees to receive reimbursement for medical marijuana expenses, others take a more restrictive approach. Some even prohibit workers’ compensation insurance from covering such costs.

For example, five states – New Hampshire, Connecticut, New Jersey, New York, and New Mexico – have already enacted laws that specifically allow reimbursing medical cannabis expenses for employees who have suffered work-related injuries. In these states, medical marijuana is considered a legitimate and necessary form of medical treatment. Injured workers are entitled to coverage for their medical expenses under workers’ compensation insurance.

On the other hand, seven states expressly prohibit workers’ compensation insurance from reimbursing medical marijuana-related costs: Massachusetts, Maine, Minnesota, North Dakota, Florida, Washington, and Ohio. These states take a more restrictive view of medical cannabis and do not recognize it as a legitimate medical treatment for work-related injuries.

The question of whether workers can receive reimbursement for medical marijuana-related costs through their workers’ compensation insurance remains a controversial topic in the US. Despite several attempts by advocacy groups to influence lawmakers and the courts, the US Supreme Court declined to weigh in on the matter last year, leaving the issue unresolved and creating inconsistencies between state and federal marijuana laws.

Advocacy groups have urged the US Supreme Court to resolve the issue and provide a more predictable legal environment since these inconsistencies have left companies and employees confused and apprehensive. The debate and legal problems surrounding the use of medicinal cannabis in the workplace are sure to continue while the situation is still up in the air, especially as additional states approve it as a medicine.

Conclusion

There is still much debate in the US over whether workers’ compensation insurance coverage should cover medical marijuana-related expenses. Even though some jurisdictions have expressly permitted such reimbursements, others have outright forbade them, and patients and employers are nevertheless left in the dark concerning their rights and obligations.

The impetus to settle these disputes will only grow as more states continue to legalize medical cannabis and acknowledge its potential advantages. The United States requires a more uniform and predictable legal framework to regulate medical cannabis usage in the workplace, whether through court decisions or legislative action.

Advocates and patients must keep fighting for their rights and advancing reforms at the state and federal levels until such a framework is implemented. We can only develop a system that genuinely prioritizes the health and well-being of all Americans by working together. (Full Story)

In category:State Bills
Next Post

Hawaii Senators Approve Bill To Create Psychedelics Advisory Council To Prepare For Federal Legalization

A Hawaii Senate committee approved a House-passed bill on Wednesday that would create an advisory council to look into possible regulations to provide access to federal “breakthrough therapies” like psilocybin and MDMA. The psychedelics legislation from Rep. Adrian Tam (D) advanced, with…
Read
Previous Post

Hawaii Won’t Legalize Marijuana This Year Despite Senate Passage, But Advocates Look To 2024

A Hawaii Senate-passed bill to legalize marijuana has stalled out in the House for the year—but advocates are shifting focus to 2024, hoping to enact the reform in the second half of the two-year legislative session. The legislation from Sen.…
Read
Random Post

Bill allowing CT hemp growers into cannabis industry approved by key panel

Connecticut's hemp farmers would be allowed a path into the cannabis industry under legislation that passed overwhelmingly Tuesday in a key legislative committee. The amended bill, which next moves to the state House of Representatives, would let dozens of small hemp…
Read
Random Post

Former Curaleaf Exec to Head iAnthus Amid RICO Suit, Alleged Mismanagement

Amid a pending lawsuit and serious allegations of funds misappropriation, Canadian producer iAnthus Capital Holdings, Inc. (CSE: IAN) (OTCPK: ITHUF) has appointed Richard Proud as its new chief executive officer and director on the board of directors. The announcement comes in the…
Read
Random Post

Small Trial Suggests DMT Can Improve Symptoms of Depression

A trial conducted by biotechnology company Small Pharma found that the psychedelic DMT could improve symptoms of depression when used in conjunction with therapy. In the study, which used intravenous DMT dosing, 14 participants out of 34 were in remission…
Read
Random Post

Despite Owning a Cannabis Brand, Kevin Smith Says He's Kicking Pot

Kevin Smith's life has not been the same ever since he suffered a massive heart attack in 2018. He trimmed down more than 100 pounds and adopted a vegan lifestyle. Now, five years after that fateful day, Smith has also…
Read